DM

Donald P. McDonnell

DU Duke University: 17 patents #38 of 2,315Top 2%
BM Baylor College Of Medicine: 3 patents #117 of 907Top 15%
LI Ligand Pharmaceuticals Incorporated: 1 patents #117 of 191Top 65%
UI University Of Illinois: 1 patents #1,166 of 3,009Top 40%
📍 Chapel Hill, NC: #158 of 1,999 inventorsTop 8%
🗺 North Carolina: #2,005 of 45,564 inventorsTop 5%
Overall (All Time): #189,006 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12414924 Lasofoxifene treatment of breast cancer Kaitlyn Andreano, Ching-yi Chang, Stephanie L. Gaillard 2025-09-16
12263142 Method of treating cancer using selective estrogen receptor modulators Suzanne E. Wardell, Erik R. Nelson 2025-04-01
12158399 CaMKK2 inhibitor compositions and methods of using the same Luigi Racioppi, Erik R. Nelson, Wei Huang, Nelson Chao 2024-12-03
11980597 Lasofoxifene treatment of breast cancer Kaitlyn Andreano, Ching-yi Chang, Stephanie L. Gaillard 2024-05-14
11974983 Lasofoxifene treatment of breast cancer Kaitlyn Andreano, Ching-yi Chang, Stephanie L. Gaillard 2024-05-07
11951080 Method of treating cancer using selective estrogen receptor modulators Suzanne E. Wardell, Erik R. Nelson 2024-04-09
11779552 Method of treating cancer using selective estrogen receptor modulators Suzanne E. Wardell, Erik R. Nelson 2023-10-10
11497730 Lasofoxifene treatment of breast cancer Kaitlyn Andreano, Ching-yi Chang, Stephanie L. Gaillard 2022-11-15
10905659 Lasofoxifene treatment of breast cancer Kaitlyn Andreano, Ching-yi Chang, Stephanie L. Gaillard 2021-02-02
10420734 Method of treating cancer using selective estrogen receptor modulators Suzanne E. Wardell, Erik R. Nelson 2019-09-24
10258604 Lasofoxifene treatment of breast cancer Kaitlyn Andreano, Ching-yi Chang, Stephanie L. Gaillard 2019-04-16
10071066 Method of treating cancer using selective estrogen receptor modulators Suzanne E. Wardell, Erik R. Nelson 2018-09-11
9999620 CaMKK-β as a target for treating cancer Daniel Frigo, Anthony R. Means 2018-06-19
9868705 Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer John A. Katzenellenbogen, John Norris, Alexander Parent, Julie Pollock, Jillian Gunther +2 more 2018-01-16
9421264 Method of treating cancer using selective estrogen receptor modulators Suzanne E. Wardell, Erik R. Nelson 2016-08-23
7307102 Method of preventing or treating estrogen-dependent diseases and disorders John Norris, Caroline Connor, Ashini Wijayaratne 2007-12-11
7238793 Estrogen receptor modulators John Norris, Daju Fan 2007-07-03
6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy Elisabetta Vegeto, Bert W. O'Malley, William T. Schrader, Ming-Jer Tsai 2003-07-29
5935934 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy Elisabetta Vegeto, Bert W. O'Malley, William T. Schrader, Ming-Jer Tsai 1999-08-10
5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy Elisabetta Vegeto, Bert W. O'Malley, William T. Schrader, Ming-Jer Tsai 1999-02-23
5506102 Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription 1996-04-09
5364791 Progesterone receptor having C. terminal hormone binding domain truncations Elisabetta Vegeto, Bert W. O'Malley 1994-11-15